Sequel Med Tech Unveils Next-Gen, DEKA-Developed Insulin Delivery System
Sequel Med Tech, in collaboration with DEKA Research & Development, is preparing to launch the twiist automated insulin delivery system, a novel device that employs a “fundamentally different” mechanism of insulin delivery and is the first FDA-cleared AID to utilize Tidepool’s Loop algorithm. Although diabetes is the company’s first target, it has larger plans in the drug-delivery space.